ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Balaxi Pharmaceuticals will hold a board meeting on August 5, 2026, to consider and approve its unaudited standalone and consolidated financial results for the June 2026 quarter.
Balaxi Pharmaceuticals scheduled a board meeting on May 28, 2026, to approve audited FY2026 financial results. Trading window remains closed until May 30, 2026.